singlecent
prospect
studi
perform
octob
april
approv
local
ethic
committe
written
inform
consent
requir
particip
patient
underw
allogen
autolog
sct
includ
patient
monitor
respiratori
viral
infect
due
influenza
viru
b
rsv
b
piv
rhinovirus
enterovirus
human
coronaviru
adenovirus
month
transplant
patient
report
respiratori
tract
ill
combin
nosethroat
swab
specimen
obtain
within
h
viral
cultur
realtim
rtpcr
detect
respiratori
virus
nosethroat
swab
specimen
also
obtain
possibl
day
initi
complaint
sampl
collect
episod
respiratori
tract
ill
defin
diagnost
sampl
addit
nosethroat
swab
specimen
obtain
time
hospit
admiss
week
transplant
monitor
asymptomat
excret
respiratori
virus
establish
diagnost
valu
detect
realtim
rtpcr
refer
surveil
sampl
diagnost
procedur
radiographi
ct
thorax
bronchoscopi
bronchoalveolar
lavag
bal
perform
basi
judgment
treat
physician
autolog
sct
patient
underw
autolog
sct
acut
leukemia
receiv
condit
regimen
either
cyclophosphamid
follow
gy
total
bodi
irradi
oral
busulphan
cyclophosphamid
recipi
autolog
sct
treat
lymphoma
multipl
myeloma
receiv
beam
prepar
regimen
bcnu
etoposid
cytarabin
melphalan
highdos
melphalan
respect
allogen
sct
patient
treat
cyclophosphamid
mgkg
iv
qd
day
follow
two
dose
total
bodi
irradi
patient
underw
voluntari
allogen
sct
unrel
donor
also
receiv
antithymocyt
globulin
mgkg
iv
qd
day
commenc
cyclophosphamid
therapi
transplant
recipi
receiv
partial
donor
marrow
cellskg
hospit
surveil
oropharynx
fece
urin
sampl
obtain
least
per
week
antibacteri
prophylaxi
consist
oral
ciprofloxacin
mg
bid
oral
amphotericin
b
mg
qid
combin
fluconazol
mg
qd
prevent
bacteremia
due
streptococci
patient
receiv
cephalothin
g
iv
time
per
day
transplant
antimicrobi
regimen
continu
granulocyt
count
cellsl
person
underw
allogen
sct
routin
receiv
valaciclovir
mg
bid
cotrimoxazol
mg
qd
first
month
transplant
person
underw
allogen
sct
posit
cytomegaloviru
test
result
first
month
sct
receiv
preemptiv
therapi
ganciclovir
hospit
patient
convalesc
singl
room
free
entri
staff
visitor
care
hand
wash
use
lowcount
microbi
food
prevent
measur
use
patient
respiratori
tract
ill
consid
hospit
acquir
symptom
develop
day
hospit
admiss
upper
respiratori
tract
ill
urti
defin
clinic
symptom
rhinorrhea
pharyng
laryng
cough
without
clinic
radiolog
evid
lower
respiratori
tract
involv
andor
hypoxemia
lrti
defin
develop
radiograph
pulmonari
abnorm
patient
sign
symptom
cough
dyspnea
sputum
product
fever
simultan
infect
differ
virus
consid
singl
episod
infect
bal
fluid
sampl
nosethroat
swab
specimen
place
tube
contain
viru
transport
medium
immedi
transport
laboratori
process
directli
store
maximum
h
nosethroat
bal
fluid
sampl
vortex
centrifug
g
min
part
supernat
use
convent
viral
cultur
shell
vial
cultur
detect
respiratori
virus
ie
adenovirus
piv
rsv
influenza
virus
picornavirus
remain
materi
store
analysi
realtim
rtpcr
bal
fluid
sampl
also
process
routin
bacteri
mycobacteri
fungal
cultur
examin
herpesvirus
total
nucleic
acid
extract
patient
materi
bal
fluid
nosethroat
swab
specimen
accord
method
boom
et
al
use
magnapur
lc
total
nucleic
acid
kit
roch
diagnost
total
nucleic
acid
directli
use
amplif
adenoviru
dna
viru
remaind
nucleic
acid
use
cdna
reaction
describ
elsewher
cdna
subsequ
use
differ
realtim
rtpcr
detect
influenza
virus
b
piv
rhinovirus
enterovirus
rsv
b
human
coronavirus
primer
probe
select
genbank
base
genom
region
high
conserv
matrix
gene
use
influenza
viru
hemagglutinin
gene
use
influenza
b
viru
region
use
picornavirus
ngene
use
rsv
b
coronavirus
hemagglutininneuraminidas
glycoprotein
gene
use
piv
hexon
gene
use
adenovirus
primer
probe
concentr
optim
realtim
taqman
pcr
perform
describ
elsewher
control
correct
isol
amplif
sampl
spike
extract
intern
control
viru
murin
encephalomyocard
viru
rna
viru
phocin
herp
viru
dna
viru
fluorogen
probe
recogn
human
respiratori
virus
label
report
dye
fam
quencher
dye
tamra
wherea
fluorogen
probe
recogn
intern
control
virus
label
report
dye
vic
use
differ
fluorogen
label
amplif
human
respiratori
viru
distinguish
amplif
intern
control
viru
descript
statist
express
median
valu
analysi
use
mcnemar
fisher
exact
test
perform
determin
degre
signific
variou
variabl
eightytwo
sct
procedur
perform
patient
nine
patient
exclud
studi
patient
refus
particip
patient
underw
followup
transplant
elsewher
remain
patient
complet
followup
sct
month
month
event
earli
death
patient
characterist
shown
tabl
data
episod
respiratori
tract
ill
patient
evalu
detect
respiratori
viru
nosethroat
swab
specimen
obtain
episod
comparison
episod
respiratori
tract
ill
without
respiratori
viru
shown
tabl
detect
respiratori
virus
episod
respiratori
tract
ill
total
nosethroat
swab
specimen
bal
fluid
sampl
obtain
episod
respiratori
tract
infect
use
convent
viral
cultur
respiratori
viru
isol
episod
tabl
compar
episod
realtim
rtpcr
use
p
pcrposit
sampl
includ
cultureposit
sampl
frequent
detect
respiratori
virus
rhinovirus
episod
adenovirus
coronavirus
detect
realtim
rtpcr
signific
differ
incid
respiratori
tract
infect
differ
sct
modal
tabl
urti
fortyon
episod
respiratori
tract
ill
urti
tabl
twentyf
episod
found
associ
respiratori
viru
realtim
rtpcr
compar
episod
viral
cultur
p
rhinoviru
predomin
respiratori
viru
urti
none
patient
progress
lrti
urti
patient
recov
complet
without
need
antivir
therapi
lrti
eleven
episod
respiratori
tract
ill
ltri
patient
lrti
admit
hospit
fever
cough
dyspnea
malais
predomin
sign
symptom
patient
case
preced
clinic
urti
episod
bronchoscopi
bal
perform
episod
nosethroat
swab
specimen
obtain
respiratori
viru
detect
viral
cultur
episod
lrti
realtim
rtpcr
episod
p
tabl
use
either
bal
fluid
sampl
n
combin
nosethroat
swab
specimen
n
bal
perform
patient
n
one
bal
fluid
sampl
contain
respiratori
virus
rhinoviru
parainfluenzaviru
patient
test
neg
respiratori
viru
bronchoscop
biopsi
reveal
caus
irradi
pneumon
invas
aspergillosi
bronchiol
obliteran
four
patient
lrti
die
patient
die
invas
aspergillosi
rhinovirusposit
patient
posttransplant
lymphoprolif
diseas
patient
respiratori
viru
detect
coronaviru
one
patient
rsv
death
latter
patient
consid
associ
respiratori
viru
lrti
episod
patient
one
treat
aerosol
ribavirin
durat
viral
detect
episod
respiratori
tract
ill
followup
nosethroat
sampl
obtain
episod
respiratori
tract
ill
episod
urti
episod
lrti
realtim
pcr
detect
respiratori
virus
longer
period
time
viral
cultur
initi
respiratori
viru
could
still
detect
mean
realtim
rtpcr
sampl
obtain
week
onset
symptom
could
detect
none
sampl
viral
cultur
p
rhinoviru
predomin
viru
sampl
follow
coronavirus
sampl
rsv
sampl
enteroviru
sampl
detect
respiratori
virus
absenc
respiratori
tract
ill
total
surveil
nosethroat
swab
specimen
obtain
patient
viral
cultur
sampl
test
posit
respiratori
virus
realtim
rtpcr
respiratori
viru
could
detect
sampl
p
tabl
rhinoviru
predomin
pathogen
surveil
sampl
sampl
coronaviru
sampl
adenoviru
sampl
also
detect
surveil
nosethroat
swab
specimen
obtain
sct
test
posit
respiratori
viru
patient
rhinoviru
patient
coronaviru
patient
none
respiratori
complaint
time
collect
three
patient
develop
urti
due
initi
detect
viru
rhinoviru
month
initi
collect
prolong
asymptomat
excret
rhinoviru
observ
patient
month
one
patient
month
prospect
studi
show
respiratori
virus
frequent
detect
adult
undergo
sct
found
incid
urti
lrti
associ
respiratori
viru
convent
viral
cultur
realtim
rtpcr
previou
retrospect
studi
also
observ
signific
increas
incid
respiratori
viru
infect
among
immunocompromis
patient
nest
rtpcr
compar
viral
cultur
report
incid
respiratori
viru
infect
adult
undergo
sct
acut
urti
lrti
rang
literatur
studi
viral
cultur
direct
immunofluoresc
examin
nosethroat
swab
nasopharyng
aspir
bal
fluid
specimen
use
data
clearli
demonstr
urti
associ
detect
respiratori
virus
contrast
studi
observ
sct
recipi
urti
progress
lrti
although
also
show
lrti
often
associ
presenc
respiratori
virus
patient
lrti
clinic
featur
pneumonia
without
made
obviou
complaint
viral
urti
previous
indic
immunocompromis
patient
respiratori
virus
may
caus
lrti
clinic
preced
urti
rather
low
overal
mortal
rate
studi
accord
recent
studi
immunocompromis
patient
respiratori
respiratori
tract
ill
wherea
earlier
literatur
mortal
rate
report
neg
result
detect
respiratori
virus
nosethroat
bal
fluid
specimen
viral
cultur
compar
realtim
rtpcr
may
due
sever
reason
sampl
method
use
combin
nosethroat
swab
specimen
instead
nasal
wash
specimen
may
influenc
result
viral
cultur
probabl
detect
rsv
sct
recipi
studi
adult
commonli
believ
shed
less
viru
children
may
result
lower
rate
detect
respiratori
viru
viral
cultur
rapid
diagnost
test
direct
antigen
detect
also
virus
coronavirus
difficult
cultur
routin
laboratori
rhinovirus
identifi
viral
cultur
realtim
rtpcr
major
caus
urti
also
detect
patient
lrti
combin
piv
outcom
surpris
immunocompet
adult
rhinovirus
account
averag
episod
common
cold
per
year
well
known
occasion
caus
lrti
older
adult
neonat
rhinovirus
describ
caus
pathogen
lrti
immunocompromis
patient
either
sole
pathogen
copathogen
bacteria
respiratori
virus
although
recent
studi
prospect
investig
incid
respiratori
viru
infect
patient
hematolog
cancer
observ
low
number
rhinoviru
infect
case
urti
lrti
rapid
detect
rhinoviru
infect
could
import
especi
patient
lrti
suggest
antivir
drug
pleconaril
could
effect
treatment
sever
picornaviru
infect
includ
infect
due
rhinovirus
sct
recipi
interest
number
human
coronavirus
detect
realtim
rtpcr
human
coronaviru
type
major
caus
common
cold
notori
difficult
cultur
virus
howev
may
sometim
caus
pneumonia
immunocompet
immunocompromis
patient
found
coronaviru
probabl
caus
ill
episod
respiratori
tract
ill
last
year
new
human
coronaviru
discov
caus
pathogen
outbreak
sever
acut
respiratori
syndrom
recent
anoth
new
coronaviru
describ
associ
lrti
find
underscor
potenti
coronavirus
caus
lrti
adenoviru
detect
surveil
sampl
followup
sampl
respiratori
tract
ill
due
adenoviru
detect
studi
popul
adenovirus
recogn
seriou
pathogen
pediatr
sct
recipi
virus
also
threat
adult
sct
recipi
thought
adenoviru
infect
sct
recipi
caus
reactiv
infect
adenoviru
also
caus
acut
upper
respiratori
diseas
spread
aerosol
although
especi
interest
adenovirus
recent
obtain
environ
caus
acut
respiratori
tract
ill
one
determin
whether
sampl
obtain
respiratori
tract
sct
recipi
reveal
recent
obtain
adenoviru
infect
reactiv
infect
latent
adenovirus
lymphoepitheli
tissu
nasopharynx
establish
diagnost
valu
realtim
rtpcr
also
analyz
nosethroat
swab
specimen
obtain
period
sct
recipi
complaint
respiratori
tract
ill
surveil
sampl
realtim
rtpcr
found
respiratori
virus
sampl
rhinovirus
recent
casecontrol
studi
acut
respiratori
infect
patient
gener
practic
netherland
show
incid
rhinoviru
among
healthi
control
subject
result
show
rhinovirus
shed
symptomfre
immunocompromis
patient
healthi
person
longer
period
time
also
interpret
valu
pcr
detect
rhinovirus
may
complic
summari
present
studi
shown
respiratori
virus
major
caus
respiratori
tract
diseas
sct
recipi
demonstr
realtim
rtpcr
much
sensit
viral
cultur
detect
respiratori
viru
infect
sct
recipi
well
case
lrti
rhinoviru
caus
major
urti
one
must
awar
rhinovirus
also
detect
occasion
asymptomat
patient
suggest
persist
shed
respiratori
virus
occur
immunocompromis
patient
